AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3311120 — intervention group
Group type: EXPERIMENTAL
Intervention: Codeine (30 mg four times daily)
Number of subjects: 11
Study 3311120 — intervention group
Group type: EXPERIMENTAL
Intervention: Promethazine (25 mg four times daily)
Number of subjects: 11
Study 3311120 — intervention group
Group type: COMPARATOR
Intervention: Comparison of Codeine and Promethazine
Number of subjects: 11
Study 31181131 — intervention group
Group type: EXPERIMENTAL
Intervention: FFS group (n = 25)
Number of subjects: 50
Study 31181131 — intervention group
Group type: COMPARATOR
Intervention: CAP group (n = 25)
Number of subjects: 50
Study 28099499 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental Formula (EF) with bovine MFGM concentrate
Number of subjects: 240
Study 28099499 — intervention group
Group type: COMPARATOR
Intervention: Standard Formula (SF)
Number of subjects: 240
Study 28099499 — intervention group
Group type: COMPARATOR
Intervention: Breast-fed Reference (BFR)
Number of subjects: 240
Study 25864939 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg single dose)
Number of subjects: 35
Study 25864939 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 23894731 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention
Number of subjects: 743
Study 21266929 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg·kg(‐1))
Number of subjects: 10
Study 21266929 — intervention group
Group type: COMPARATOR
Intervention: Placebo (dextrose)
Number of subjects: 10
Study 19702708 — intervention group
Group type: EXPERIMENTAL
Intervention: Tisseel fibrin glue
Number of subjects: 50
Study 19702708 — intervention group
Group type: COMPARATOR
Intervention: Vicryl sutures
Number of subjects: 50
Study 17225370 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based CR (home-CR)
Number of subjects: 61
Study 17225370 — intervention group
Group type: COMPARATOR
Intervention: Traditional CR (trad-CR)
Number of subjects: 61
Study 15514503 — intervention group
Group type: EXPERIMENTAL
Intervention: FIO2 0.26
Number of subjects: 19
Study 15514503 — intervention group
Group type: EXPERIMENTAL
Intervention: FIO2 0.60
Number of subjects: 19
Study 15514503 — intervention group
Group type: COMPARATOR
Intervention: FIO2 0.21 (control)
Number of subjects: 19
Study 11133611 — intervention group
Group type: EXPERIMENTAL
Intervention: 30% Oxygen group
Number of subjects: 240
Study 11133611 — intervention group
Group type: EXPERIMENTAL
Intervention: 80% Oxygen group
Number of subjects: 240
Study 11133611 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron group
Number of subjects: 240
Study 9624028 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-acting antibiotics for 5 days
Number of subjects: 0
Study 9624028 — intervention group
Group type: COMPARATOR
Intervention: Short-acting antibiotics for 8 to 10 days
Number of subjects: 0
Study 9624028 — intervention group
Group type: COMPARATOR
Intervention: Long course of short-acting antibiotics
Number of subjects: 0
Study 9624028 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone or azithromycin
Number of subjects: 0
Study 9624028 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-acting antibiotics
Number of subjects: 0
Study 7911624 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide under hydrocolloid dressing (Duoderm E)
Number of subjects: 0
Study 7911624 — intervention group
Group type: COMPARATOR
Intervention: Triamcinolone acetonide monotherapy
Number of subjects: 0
Study 7911624 — intervention group
Group type: COMPARATOR
Intervention: Hydrocolloid dressing monotherapy
Number of subjects: 0
Study 7911624 — intervention group
Group type: COMPARATOR
Intervention: Triamcinolone acetonide under plastic occlusion (Opsite IV 3000)
Number of subjects: 0
Study 7911624 — intervention group
Group type: COMPARATOR
Intervention: Hydrocolloid dressing (Duoderm E)
Number of subjects: 0
Study 2912014 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat, restricted (R) diet (800 kcal)
Number of subjects: 26
Study 2912014 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (X)
Number of subjects: 26
Study 2912014 — intervention group
Group type: COMPARATOR
Intervention: Nonexercise (NX)
Number of subjects: 26
Study 2912014 — intervention group
Group type: COMPARATOR
Intervention: Low-fat, ad libitum-carbohydrate (AL) diet
Number of subjects: 26
Study 1093603 — intervention group
Group type: EXPERIMENTAL
Intervention: Method 2: Open drainage with primary suture and pelvic peritoneal floor reconstituted
Number of subjects: 106
Study 1093603 — intervention group
Group type: EXPERIMENTAL
Intervention: Method 3: Primary suture with unsutured pelvic peritoneal floor
Number of subjects: 106
Study 1093603 — intervention group
Group type: COMPARATOR
Intervention: Control: Open drainage
Number of subjects: 106
Study 31536837 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g of TXA for every 1000 mL of the distending medium
Number of subjects: 80
Study 31536837 — intervention group
Group type: COMPARATOR
Intervention: 10 mL of placebo (10 mL of 1.5% glycine) in the same form inside every 1000 mL of the distention medium
Number of subjects: 80
Study 31557812 — intervention group
Group type: EXPERIMENTAL
Intervention: Polar M400 use and twice‐weekly social cognitive theory‐ and self‐determination theory‐based Facebook‐delivered health education intervention
Number of subjects: 38
Study 31557812 — intervention group
Group type: COMPARATOR
Intervention: Enrollment only in separate, but content‐identical, Facebook intervention
Number of subjects: 38
Study 29101095 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone CBT app (Kokoro-app) in addition to medication change
Number of subjects: 164
Study 26477119 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction intervention
Number of subjects: 0
Study 26477119 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost per quality-adjusted life year
Number of subjects: 0
Study 23619509 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 246
Study 23619509 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 246
Study 23619509 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive tests
Number of subjects: 246
Study 21991727 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg/kg tramadol (group T, n = 35)
Number of subjects: 70
Study 21991727 — intervention group
Group type: COMPARATOR
Intervention: 1 mg/kg lidocaine 2% (group L, n = 35)
Number of subjects: 70
Study 18951624 — intervention group
Group type: EXPERIMENTAL
Intervention: High phonetic combinability characters
Number of subjects: 0
Study 18951624 — intervention group
Group type: EXPERIMENTAL
Intervention: High consistency characters
Number of subjects: 0
Study 18951624 — intervention group
Group type: EXPERIMENTAL
Intervention: High combinability or high consistency characters
Number of subjects: 0
Study 18951624 — intervention group
Group type: EXPERIMENTAL
Intervention: Phonetic consistency effects
Number of subjects: 0
Study 16762079 — intervention group
Group type: EXPERIMENTAL
Intervention: Modular care involving individualised modules with choice, goal-setting, and coaching
Number of subjects: 0
Study 16762079 — intervention group
Group type: COMPARATOR
Intervention: Conventional care as directed by the participant's doctors
Number of subjects: 0
Study 16762079 — intervention group
Group type: COMPARATOR
Intervention: Contemporary reference group attending CR
Number of subjects: 0
Study 14973336 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented feedback of the obtained trajectories on a computer screen in real time
Number of subjects: 0
Study 14973336 — intervention group
Group type: COMPARATOR
Intervention: Normal vision
Number of subjects: 0
Study 11322206 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 MU IFN daily
Number of subjects: 24
Study 11322206 — intervention group
Group type: COMPARATOR
Intervention: 5 MU twice-daily
Number of subjects: 24
Study 9196668 — intervention group
Group type: EXPERIMENTAL
Intervention: Inter-ocular temporal asynchrony (IOTA) system
Number of subjects: 28
Study 9196668 — intervention group
Group type: COMPARATOR
Intervention: Monocular neutral density filters
Number of subjects: 28
Study 8646870 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate cream, 0.05%
Number of subjects: 100
Study 8646870 — intervention group
Group type: COMPARATOR
Intervention: Betamethasone valerate cream, 0.1%
Number of subjects: 100
Study 2258448 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenfluramine 40‐120 mg/day
Number of subjects: 15
Study 2258448 — intervention group
Group type: COMPARATOR
Intervention: Desipramine (control)
Number of subjects: 15
Study 7416558 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline 2.5 mg
Number of subjects: 16
Study 7416558 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline 130 mg
Number of subjects: 16
Study 7416558 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Theophylline 130 mg and Terbutaline 2.5 mg
Number of subjects: 16
Study 7416558 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 31918748 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-acupuncture
Number of subjects: 84
Study 31918748 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 84
Study 30694211 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured exercise training (SET)
Number of subjects: 0
Study 30694211 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot exercises activating calf muscles
Number of subjects: 0
Study 30694211 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 0
Study 28382660 — intervention group
Group type: EXPERIMENTAL
Intervention: Threshold inspiratory muscle training (5 sessions per week, 21-30 min per session, over 8 weeks)
Number of subjects: 55
Study 28382660 — intervention group
Group type: COMPARATOR
Intervention: Control group (medical treatment and routine care only, without intervention)
Number of subjects: 55
Study 26424607 — intervention group
Group type: EXPERIMENTAL
Intervention: Scheduling plus appointment text message reminders
Number of subjects: 2054
Study 26424607 — intervention group
Group type: COMPARATOR
Intervention: Appointment text message reminder-only
Number of subjects: 2054
Study 26424607 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2054
Study 26424607 — intervention group
Group type: EXPERIMENTAL
Intervention: Scheduling plus appointment text message reminders (for children without a baseline appointment)
Number of subjects: 2054
Study 26424607 — intervention group
Group type: COMPARATOR
Intervention: Appointment text message reminder-only (for children without a baseline appointment)
Number of subjects: 2054
Study 26424607 — intervention group
Group type: COMPARATOR
Intervention: Usual care (for children without a baseline appointment)
Number of subjects: 2054
Study 24656175 — intervention group
Group type: EXPERIMENTAL
Intervention: JE-CV
Number of subjects: 8
Study 21822980 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological intervention
Number of subjects: 114
Study 21822980 — intervention group
Group type: COMPARATOR
Intervention: Health education session
Number of subjects: 114
Study 20864724 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention with FOBT kit
Number of subjects: 548
Study 20864724 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention without FOBT kit
Number of subjects: 548
Study 20864724 — intervention group
Group type: COMPARATOR
Intervention: Control group (education on physical activity)
Number of subjects: 548
Study 18614727 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolus tube feeding (6.93 ± 0.38 MJ/d of 4.18 kJ/mL multinutrient feed)
Number of subjects: 6
Study 18614727 — intervention group
Group type: COMPARATOR
Intervention: Placebo boluses (<0.4 MJ/d)
Number of subjects: 6
Study 18614727 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolus tube feeding
Number of subjects: 6
Study 16094059 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive lifestyle changes
Number of subjects: 93
Study 16094059 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 93
Study 12108334 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous interleukin-2
Number of subjects: 0
Study 12108334 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alone
Number of subjects: 0
Study 12108334 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of interleukin-2 and interferon
Number of subjects: 0
Study 12108334 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroup of patients with >70% probability of progression
Number of subjects: 0
Study 12108334 — intervention group
Group type: EXPERIMENTAL
Intervention: s.c. cytokine regimens
Number of subjects: 0
Study 12108334 — intervention group
Group type: COMPARATOR
Intervention: Overall survival
Number of subjects: 0
Study 10774700 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilazep
Number of subjects: 17
Study 10774700 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 8646822 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin (400 mg orally three times a day for 10 days)
Number of subjects: 12
Study 8646822 — intervention group
Group type: COMPARATOR
Intervention: Placebo (matched placebo given orally three times a day for 10 days)
Number of subjects: 12
Study 1475039 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg pyritinol dihydrochloride-monohydrate, 3 times daily for 12 weeks
Number of subjects: 164
Study 1475039 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 164
Study 6706234 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant therapy (various modalities)
Number of subjects: 656
Study 6706234 — intervention group
Group type: COMPARATOR
Intervention: No further treatment after primary surgery
Number of subjects: 656
Study 6706234 — intervention group
Group type: COMPARATOR
Intervention: Tumors of borderline malignancy or stage Ia(i) well-differentiated tumors
Number of subjects: 656
Study 6706234 — intervention group
Group type: EXPERIMENTAL
Intervention: Clear cell carcinoma
Number of subjects: 656
Study 30635064 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditative intervention commencing two weeks before surgery for four weeks post-surgery
Number of subjects: 40
Study 30635064 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditative intervention commencing from the day after surgery for four weeks post-surgery
Number of subjects: 40
Study 30635064 — intervention group
Group type: COMPARATOR
Intervention: Standard of care with no meditative intervention
Number of subjects: 40
Study 30063162 — intervention group
Group type: EXPERIMENTAL
Intervention: Guardian Connect system (mobile device with software application)
Number of subjects: 145
Study 30063162 — intervention group
Group type: EXPERIMENTAL
Intervention: Guardian Link 3 transmitter (Glucose Sensor Recorder)
Number of subjects: 145
Study 30063162 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall results for both systems
Number of subjects: 145
Study 25427553 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative treatment without reduction of the fracture
Number of subjects: 85
Study 25427553 — intervention group
Group type: COMPARATOR
Intervention: Closed reduction and bouquet pinning
Number of subjects: 85
Study 23769752 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational brochure mailed to families prior to VCUG
Number of subjects: 105
Study 23769752 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational brochure)
Number of subjects: 105
Study 23769752 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (experimental and control)
Number of subjects: 105
Study 21283007 — intervention group
Group type: EXPERIMENTAL
Intervention: β-blocker therapy
Number of subjects: 1327
Study 18763027 — intervention group
Group type: EXPERIMENTAL
Intervention: etanercept 50 mg twice weekly
Number of subjects: 30
Study 18763027 — intervention group
Group type: COMPARATOR
Intervention: acitretin 0.4 mg/kg per day
Number of subjects: 30
Study 17367446 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral testosterone (Sustanon 250 intramuscular injection)
Number of subjects: 13
Study 17367446 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole 2.5 mg orally daily
Number of subjects: 13
Study 15303278 — intervention group
Group type: EXPERIMENTAL
Intervention: Gene expression profiles in cardiac myocytes with normal sinus rhythm
Number of subjects: 17
Study 15303278 — intervention group
Group type: EXPERIMENTAL
Intervention: Weighted-distance method for arrhythmia prediction
Number of subjects: 17
Study 15303278 — intervention group
Group type: EXPERIMENTAL
Intervention: Calculation formulae for left ventricular ejection fraction
Number of subjects: 17
Study 11580123 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedicle screw fixation
Number of subjects: 130
Study 11580123 — intervention group
Group type: COMPARATOR
Intervention: Uninstrumented fusion
Number of subjects: 130
Study 11580123 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (pedicle screw fixation and uninstrumented fusion)
Number of subjects: 130
Study 8229622 — intervention group
Group type: EXPERIMENTAL
Intervention: Counter-rotational powered brush (CRPB)
Number of subjects: 40
Study 8229622 — intervention group
Group type: COMPARATOR
Intervention: Control oral hygiene methods
Number of subjects: 40
Study 3543347 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral paramedian incision
Number of subjects: 431
Study 3543347 — intervention group
Group type: COMPARATOR
Intervention: Midline incision
Number of subjects: 431
Study 31938803 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 30400784 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based physical activity promotion program (6-month access)
Number of subjects: 0
Study 30400784 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based physical activity promotion program plus physiotherapy counselling (remote support)
Number of subjects: 0
Study 30400784 — intervention group
Group type: COMPARATOR
Intervention: Usual care with a leaflet containing physical activity guidelines
Number of subjects: 0
Study 26463007 — intervention group
Group type: EXPERIMENTAL
Intervention: L-epinephrine plus dexamethasone
Number of subjects: 174
Study 26463007 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone (Control)
Number of subjects: 174
Study 25551810 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided fascia iliaca compartment block (FICB)
Number of subjects: 70
Study 25551810 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 in 1 block
Number of subjects: 70
Study 25551810 — intervention group
Group type: COMPARATOR
Intervention: No block (Control group)
Number of subjects: 70
Study 23545863 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan 0.1 μg/kg/min
Number of subjects: 30
Study 23545863 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 20724766 — intervention group
Group type: EXPERIMENTAL
Intervention: Nigella sativa
Number of subjects: 30
Study 20724766 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 30
Study 18446781 — intervention group
Group type: EXPERIMENTAL
Intervention: Early closure (EC; 8 days)
Number of subjects: 186
Study 18446781 — intervention group
Group type: COMPARATOR
Intervention: Late closure (LC; 2 months)
Number of subjects: 186
Study 16354143 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching module with guided discussion and practice highlighting use of a mnemonic
Number of subjects: 43
Study 16354143 — intervention group
Group type: COMPARATOR
Intervention: General discussion and provision of the mnemonic at the end of the session
Number of subjects: 43
Study 14568987 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose etoposide, ifosfamide, and cisplatin (VIP) chemotherapy plus autologous stem cell support, administered in one cycle followed by three to four sequential cycles every 3 weeks.
Number of subjects: 221
Study 14568987 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose VIP chemotherapy with stem cell support.
Number of subjects: 221
Study 14568987 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose level 6 of high-dose VIP (cisplatin 100 mg/m2, etoposide 1500 mg/m2, ifosfamide 10 g/m2) recommended for further investigation.
Number of subjects: 221
Study 10910864 — intervention group
Group type: EXPERIMENTAL
Intervention: Amsorb (A; Armstrong Medical, Coleraine, Northern Ireland)
Number of subjects: 0
Study 10910864 — intervention group
Group type: EXPERIMENTAL
Intervention: Drägersorb 800 Plus (D; Dräger, Luebeck, Germany)
Number of subjects: 0
Study 10910864 — intervention group
Group type: EXPERIMENTAL
Intervention: Medisorb (M; Datex‐Ohmeda, Bromma, Sweden)
Number of subjects: 0
Study 10910864 — intervention group
Group type: COMPARATOR
Intervention: Drägersorb 800 (C)
Number of subjects: 0
Study 8877265 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrophysiologic Study
Number of subjects: 0
Study 8877265 — intervention group
Group type: COMPARATOR
Intervention: Holter Monitoring
Number of subjects: 0
Study 1455371 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemosorption weekly for 3 weeks, followed by cyclophosphamide 1000 mg IV after the second procedure, then methotrexate 7.5 mg weekly.
Number of subjects: 32
Study 1455371 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate 7.5 mg weekly.
Number of subjects: 32
Study 1455371 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide 200 mg IV twice a week for 6 times, then 200 mg weekly orally until a total dose of 2 g.
Number of subjects: 32
Study 1455371 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine 100 mg daily.
Number of subjects: 32
Study 3334188 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine at 300 mg daily for the control of symptoms of non-ulcer dyspepsia
Number of subjects: 45
Study 3334188 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 29746903 — intervention group
Group type: EXPERIMENTAL
Intervention: famciclovir 500mg (one tablet) three times daily for 7 days
Number of subjects: 174
Study 29746903 — intervention group
Group type: COMPARATOR
Intervention: acyclovir 800mg (two capsules) five times daily for 7 days
Number of subjects: 174
Study 27354043 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting nifedipine (10-60 mg/day)
Number of subjects: 100
Study 27354043 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatments alone
Number of subjects: 100
Study 24355438 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein pulse feeding (PD), 72% of dietary protein consumed in one meal at noon, averaging 1.31 g/kg body weight daily
Number of subjects: 66